A complement-blocking treatment for specified blood, kidney, and neurological disorders, including PNH and atypical HUS.
Profile scope: Ravulizumab-cwvz injection. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Headache, digestive symptoms, muscle or joint discomfort, or respiratory symptoms may occur.
Serious risks and warning signs
Meningococcal infection can become rapidly fatal, and vaccination does not eliminate the risk. Fever with headache, stiff neck, rash, confusion, or marked illness needs emergency assessment. Other serious infections are possible.
A question for your healthcare team
Which vaccines, preventive measures, safety-card instructions, and infection precautions apply during and after my treatment?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.